The Next Frontier in HIV Innovation: The Transition to No Transmission

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
In its 40-year lifetime, the HIV epidemic has shifted from a death sentence to a manageable condition, thanks to life-saving medical advances. But with the evolution of this epidemic comes the need to reassess patient needs and treatment goals. This virus never stops evolving – so we too need to evolve and innovate faster.

During this session, experts will share the key areas influencing the future of the HIV epidemic, including the need for meaningful biopharma innovation to address unmet needs, breakthrough R&D, public health solutions and politics to drive change and stop the spread of the epidemic.
Moderator
photo
Science Journalist
Speakers
photo
Executive Vice President & Chief Patient Officer
Merck & Co, Inc.
photo
Founding Executive Director
Prevention Access Campaign
photo
Director, Joseph W. Blount Center for Health and Human Rights
Emory University
photo
Executive Director
AVAC